{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:42:31Z","timestamp":1789720951232,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010905","name":"Major Research Plan","doi-asserted-by":"publisher","award":["12331018"],"award-info":[{"award-number":["12331018"]}],"id":[{"id":"10.13039\/501100010905","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Math. Biol."],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00285-025-02220-1","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T01:19:10Z","timestamp":1747358350000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Optimal adaptive therapeutic schedules for metastatic castrate-resistant prostate cancer based on bilevel optimization problem"],"prefix":"10.1007","volume":"90","author":[{"given":"Dujuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2670-6760","authenticated-orcid":false,"given":"Jinzhi","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"issue":"4","key":"2220_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00285-024-02062-3","volume":"88","author":"FE Alvarez","year":"2024","unstructured":"Alvarez FE, Viossat Y (2024) Tumor containment: a more general mathematical analysis. J Math Biol 88(4):41. https:\/\/doi.org\/10.1007\/s00285-024-02062-3","journal-title":"J Math Biol"},{"issue":"15","key":"2220_CR2","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.3390\/cancers13153674","volume":"13","author":"M Archetti","year":"2021","unstructured":"Archetti M (2021) Collapse of intra-tumor cooperation induced by engineered defector cells. Cancers (Basel) 13(15):3674. https:\/\/doi.org\/10.3390\/cancers13153674","journal-title":"Cancers (Basel)"},{"issue":"3","key":"2220_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s40261-019-00752-1","volume":"39","author":"M Bouhajib","year":"2019","unstructured":"Bouhajib M, Tayab Z (2019) Evaluation of the pharmacokinetics of abiraterone acetate and abiraterone following single-dose administration of abiraterone acetate to healthy subjects. Clin Drug Investig 39(3):309\u2013317. https:\/\/doi.org\/10.1007\/s40261-019-00752-1","journal-title":"Clin Drug Investig"},{"issue":"1","key":"2220_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41573-019-0044-1","volume":"19","author":"S Boumahdi","year":"2020","unstructured":"Boumahdi S, de Sauvage FJ (2020) The great escape: tumour cell plasticity in resistance to targeted therapy. Nat Rev Drug Discov 19(1):39\u201356. https:\/\/doi.org\/10.1038\/s41573-019-0044-1","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"2220_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3322\/canjclin.45.3.148","volume":"45","author":"MK Brawer","year":"1995","unstructured":"Brawer MK (1995) How to use prostate-specific antigen in the early detection or screening for prostatic carcinoma. CA Cancer J Clin 45(3):148\u2013164. https:\/\/doi.org\/10.3322\/canjclin.45.3.148","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"2220_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"2220_CR7","first-page":"2275","volume":"50","author":"N Bruchovsky","year":"1990","unstructured":"Bruchovsky N, Rennie PS, Coldman AJ, Larry Goldenberg S, To M, Lawson D (1990) Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma. Cancer Res 50(8):2275\u20132282","journal-title":"Cancer Res"},{"issue":"12","key":"2220_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243386","volume":"15","author":"J Cunningham","year":"2020","unstructured":"Cunningham J, Thuijsman F, Peeters R, Viossat Y, Brown J, Gatenby R, Sta\u0148kov\u00e1 K (2020) Optimal control to reach eco-evolutionary stability in metastatic castrate-resistant prostate cancer. PLoS ONE 15(12):e0243386. https:\/\/doi.org\/10.1371\/journal.pone.0243386","journal-title":"PLoS ONE"},{"issue":"1","key":"2220_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1745-6150-5-24","volume":"5","author":"SE Eikenberry","year":"2010","unstructured":"Eikenberry SE, Nagy JD, Kuang Y (2010) The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model. Biol Direct 5(1):1\u201328. https:\/\/doi.org\/10.1186\/1745-6150-5-24","journal-title":"Biol Direct"},{"issue":"11","key":"2220_CR10","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1158\/0008-5472.CAN-23-2040","volume":"84","author":"K Gallagher","year":"2024","unstructured":"Gallagher K, Strobl MA, Park DS, Spoendlin FC, Gatenby RA, Maini PK, Anderson AR (2024) Mathematical model-driven deep learning enables personalized adaptive therapy. Cancer Res 84(11):1929\u20131941. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-2040","journal-title":"Cancer Res"},{"issue":"11","key":"2220_CR11","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a040972","volume":"10","author":"RA Gatenby","year":"2020","unstructured":"Gatenby RA, Brown JS (2020) The evolution and ecology of resistance in cancer therapy. Cold Spring Harb Perspect Med 10(11):a040972. https:\/\/doi.org\/10.1101\/cshperspect.a040972","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"11","key":"2220_CR12","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.1158\/0008-5472.CAN-08-3658","volume":"69","author":"RA Gatenby","year":"2009","unstructured":"Gatenby RA, Silva AS, Gillies RJ, Frieden BR (2009) Adaptive therapy. Cancer Res 69(11):4894\u20134903. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-3658","journal-title":"Cancer Res"},{"key":"2220_CR13","unstructured":"Goldman L, Cooney KA (2023). Goldman-Cecil Medicine (27th ed.). Elsevier"},{"issue":"1","key":"2220_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1017\/s0334270000004768","volume":"27","author":"K Gopalsamy","year":"1985","unstructured":"Gopalsamy K (1985) Global asymptotic stability in a periodic Lotka-Volterra system. ANZIAM J 27(1):66\u201372. https:\/\/doi.org\/10.1017\/s0334270000004768","journal-title":"ANZIAM J"},{"issue":"12","key":"2220_CR15","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.3390\/cancers12123556","volume":"12","author":"E Hansen","year":"2020","unstructured":"Hansen E, Read AF (2020) Modifying adaptive therapy to enhance competitive suppression. Cancers (Basel) 12(12):3556. https:\/\/doi.org\/10.3390\/cancers12123556","journal-title":"Cancers (Basel)"},{"issue":"4","key":"2220_CR16","first-page":"293","volume":"1","author":"C Huggins","year":"1941","unstructured":"Huggins C, Hodges CV et al (1941) Studies on prostatic cancer. Cancer Res 1(4):293\u2013297","journal-title":"Cancer Res"},{"issue":"49","key":"2220_CR17","doi-asserted-by":"publisher","first-page":"19701","DOI":"10.1073\/pnas.1115750108","volume":"108","author":"HV Jain","year":"2011","unstructured":"Jain HV, Clinton SK, Bhinder A, Friedman A (2011) Mathematical modeling of prostate cancer progression in response to androgen ablation therapy. Proc Natl Acad Sci USA 108(49):19701\u201319706. https:\/\/doi.org\/10.1073\/pnas.1115750108","journal-title":"Proc Natl Acad Sci USA"},{"issue":"07","key":"2220_CR18","first-page":"1532","volume":"32","author":"W Jiao","year":"2010","unstructured":"Jiao W, Liu G, Zhang Y (2010) Particle swarm optimization based on simulated annealing for solving constrained optimization problems. Syst Eng Electron 32(07):1532\u20131536","journal-title":"Syst Eng Electron"},{"issue":"5","key":"2220_CR19","doi-asserted-by":"publisher","first-page":"767","DOI":"10.5114\/aoms.2012.31610","volume":"3635","author":"P Kawalec","year":"2012","unstructured":"Kawalec P, Paszulewicz A, Holko P, Pilc A (2012) Sipuleucel-T immunotherapy for castration-resistant prostate cancer A systematic review and meta-analysis. Arch Med Sci 3635(5):767\u201375. https:\/\/doi.org\/10.5114\/aoms.2012.31610","journal-title":"Arch Med Sci"},{"issue":"11","key":"2220_CR20","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1002\/1097-0142(19861201)58:11<2546::AID-CNCR2820581131>3.0.CO;2-N","volume":"58","author":"LH Klotz","year":"1986","unstructured":"Klotz LH, Herr HW, Morse MJ, Whitmore WF Jr (1986) Intermittent endocrine therapy for advanced prostate cancer. Cancer 58(11):2546\u20132550","journal-title":"Cancer"},{"issue":"8","key":"2220_CR21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11538-023-01178-9","volume":"85","author":"A Laruelle","year":"2023","unstructured":"Laruelle A, Rocha A, Manini C, Lopez JI, Inarra E (2023) Effects of heterogeneity on cancer: a game theory perspective. Bull Math Biol 85(8):72. https:\/\/doi.org\/10.1007\/s11538-023-01178-9","journal-title":"Bull Math Biol"},{"key":"2220_CR22","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.apm.2022.03.004","volume":"107","author":"R Liu","year":"2022","unstructured":"Liu R, Wang S, Tan X, Zou X (2022) Identifying optimal adaptive therapeutic schedules for prostate cancer through combining mathematical modeling and dynamic optimization. Appl Math Model 107:688\u2013700. https:\/\/doi.org\/10.1016\/j.apm.2022.03.004","journal-title":"Appl Math Model"},{"issue":"6","key":"2220_CR23","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1210\/jcem-49-6-905","volume":"49","author":"PC Macdonald","year":"1979","unstructured":"Macdonald PC, Madden JD, Brenner PF, Wilson JD, Siiteri PK (1979) Origin of estrogen in normal men and in women with testicular feminization. J Clin Endocrinol Metab 49(6):905\u2013916. https:\/\/doi.org\/10.1210\/jcem-49-6-905","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2220_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/00401706.2000.10485979","volume":"42","author":"MD McKay","year":"2000","unstructured":"McKay MD, Beckman RJ, Conover WJ (2000) A comparison of three methods for selecting values of input variables in the analysis of output from a computer code. Technometrics 42(1):55\u201361. https:\/\/doi.org\/10.1080\/00401706.2000.10485979","journal-title":"Technometrics"},{"issue":"3","key":"2220_CR25","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3390\/biomedicines10030689","volume":"10","author":"J Morote","year":"2022","unstructured":"Morote J, Aguilar A, Planas J, Trilla E (2022) Definition of castrate resistant prostate cancer: new insights. Biomedicines 10(3):689. https:\/\/doi.org\/10.3390\/biomedicines10030689","journal-title":"Biomedicines"},{"issue":"18","key":"2220_CR26","doi-asserted-by":"publisher","first-page":"5913","DOI":"10.1158\/1078-0432.CCR-11-0728","volume":"17","author":"EA Mostaghel","year":"2011","unstructured":"Mostaghel EA, Marck BT, Plymate SR, Vessella RL, Balk S, Matsumoto AM, Nelson PS, Montgomery RB (2011) Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: induction of steroidogenesis and androgen receptor splice variants. Clin Cancer Res 17(18):5913\u20135925. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-0728","journal-title":"Clin Cancer Res"},{"issue":"12","key":"2220_CR27","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a030361","volume":"8","author":"CH Pernar","year":"2018","unstructured":"Pernar CH, Ebot EM, Wilson KM, Mucci LA (2018) The epidemiology of prostate cancer. Cold Spring Harb Perspect Med 8(12):a030361. https:\/\/doi.org\/10.1101\/cshperspect.a030361","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"8","key":"2220_CR28","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.3390\/app10082721","volume":"10","author":"T Phan","year":"2020","unstructured":"Phan T, Crook SM, Bryce AH, Maley CC, Kostelich EJ, Kuang Y (2020) Review: Mathematical modeling of prostate cancer and clinical application. Appl Sci 10(8):2721. https:\/\/doi.org\/10.3390\/app10082721","journal-title":"Appl Sci"},{"issue":"1","key":"2220_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-020-0717-8","volume":"12","author":"JK Sa","year":"2020","unstructured":"Sa JK, Hong JY, Lee IK, Js Kim, Sim MH, Kim HJ, An JY, Sohn TS, Lee JH, Bae JM et al (2020) Comprehensive pharmacogenomic characterization of gastric cancer. Genome Med 12(1):1\u201312. https:\/\/doi.org\/10.1186\/s13073-020-0717-8","journal-title":"Genome Med"},{"key":"2220_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2019.100646","volume":"47","author":"AB Sarmento-Ribeiro","year":"2019","unstructured":"Sarmento-Ribeiro AB, Scorilas A, Goncalves AC, Efferth T, Trougakos IP (2019) The emergence of drug resistance to targeted cancer therapies: clinical evidence. Drug Resist Updat 47:100646. https:\/\/doi.org\/10.1016\/j.drup.2019.100646","journal-title":"Drug Resist Updat"},{"issue":"1","key":"2220_CR31","first-page":"1","volume":"12","author":"ND Shore","year":"2010","unstructured":"Shore ND, Crawford ED (2010) Intermittent androgen deprivation therapy: redefining the standard of care? Rev Urol 12(1):1\u201311","journal-title":"Rev Urol"},{"issue":"24","key":"2220_CR32","doi-asserted-by":"publisher","first-page":"6362","DOI":"10.1158\/0008-5472.CAN-12-2235","volume":"72","author":"AS Silva","year":"2012","unstructured":"Silva AS, Kam Y, Khin ZP, Minton SE, Gillies RJ, Gatenby RA (2012) Evolutionary approaches to prolong progression-free survival in breast cancer. Cancer Res 72(24):6362\u20136370. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-2235","journal-title":"Cancer Res"},{"issue":"8","key":"2220_CR33","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.ejca.2006.01.029","volume":"42","author":"N Spry","year":"2006","unstructured":"Spry N, Kristjanson L, Hooton B, Hayden L, Neerhut G, Gurney H, Corica T, Korbel E, Weinstein S, McCaul K (2006) Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer. Eur J Cancer 42(8):1083\u20131092. https:\/\/doi.org\/10.1016\/j.ejca.2006.01.029","journal-title":"Eur J Cancer"},{"issue":"15","key":"2220_CR34","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1056\/NEJM198710083171501","volume":"317","author":"TA Stamey","year":"1987","unstructured":"Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E (1987) Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317(15):909\u2013916. https:\/\/doi.org\/10.1056\/NEJM198710083171501","journal-title":"N Engl J Med"},{"issue":"1","key":"2220_CR35","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0021-9258(18)89753-8","volume":"260","author":"AJ Syms","year":"1985","unstructured":"Syms AJ, Norris JS, Panko WB, Smith RG (1985) Mechanism of androgen-receptor augmentation: Analysis of receptor synthesis and degradation by the density-shift technique. J Biol Chem 260(1):455\u2013461. https:\/\/doi.org\/10.1016\/S0021-9258(18)89753-8","journal-title":"J Biol Chem"},{"key":"2220_CR36","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.biopha.2018.02.067","volume":"101","author":"A Thakur","year":"2018","unstructured":"Thakur A, Roy A, Ghosh A, Chhabra M, Banerjee S (2018) Abiraterone acetate in the treatment of prostate cancer. Biomed Pharmacother 101:211\u2013218. https:\/\/doi.org\/10.1016\/j.biopha.2018.02.067","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2220_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-4682-1-9","volume":"1","author":"TM Washington","year":"2004","unstructured":"Washington TM, Blum JJ, Reed MC, Conn PM (2004) A mathematical model for lh release in response to continuous and pulsatile exposure of gonadotrophs to GnRH. Theor Biol Med Model 1(1):1\u201317. https:\/\/doi.org\/10.1186\/1742-4682-1-9","journal-title":"Theor Biol Med Model"},{"issue":"3","key":"2220_CR38","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.envsoft.2013.09.031","volume":"50","author":"H Wei","year":"2007","unstructured":"Wei H, Nearing M, Stone J (2007) A comprehensive sensitivity analysis framework for model evaluation and improvement using a case study of the rangeland hydrology and erosion model. Trans ASABE 50(3):945\u2013953. https:\/\/doi.org\/10.1016\/j.envsoft.2013.09.031","journal-title":"Trans ASABE"},{"issue":"7","key":"2220_CR39","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1158\/0008-5472.CAN-19-2669","volume":"80","author":"J West","year":"2020","unstructured":"West J, You L, Zhang J, Gatenby RA, Brown JS, Newton PK, Anderson AR (2020) Towards multidrug adaptive therapy. Cancer Res 80(7):1578\u20131589. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-2669","journal-title":"Cancer Res"},{"issue":"S3","key":"2220_CR40","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1002\/1097-0142(19930201)71:3+<1098::AID-CNCR2820711432>3.0.CO;2-G","volume":"71","author":"A Yagoda","year":"1993","unstructured":"Yagoda A, Petrylak D (1993) Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer. Cancer 71(S3):1098\u20131109","journal-title":"Cancer"},{"issue":"4","key":"2220_CR41","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00285-022-01726-2","volume":"84","author":"JL Zapata","year":"2022","unstructured":"Zapata JL, Mart\u00ednez E, Crespo F (2022) Modified quasispecies model: the analysis of a periodic therapy. J Math Biol 84(4):29. https:\/\/doi.org\/10.1007\/s00285-022-01726-2","journal-title":"J Math Biol"},{"key":"2220_CR42","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.76284","volume":"11","author":"J Zhang","year":"2022","unstructured":"Zhang J, Cunningham J, Brown J, Gatenby R (2022) Evolution-based mathematical models significantly prolong response to abiraterone in metastatic castrate-resistant prostate cancer and identify strategies to further improve outcomes. eLife 11:e76284","journal-title":"eLife"},{"issue":"1","key":"2220_CR43","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1038\/s41467-017-01968-5","volume":"8","author":"J Zhang","year":"2017","unstructured":"Zhang J, Fishman MN, Brown J, Gatenby RA (2017) Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer. Nat Commun 8(1):1816. https:\/\/doi.org\/10.1038\/s41467-017-01968-5","journal-title":"Nat Commun"}],"container-title":["Journal of Mathematical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00285-025-02220-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00285-025-02220-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00285-025-02220-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T03:38:36Z","timestamp":1748662716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00285-025-02220-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2220"],"URL":"https:\/\/doi.org\/10.1007\/s00285-025-02220-1","relation":{},"ISSN":["0303-6812","1432-1416"],"issn-type":[{"value":"0303-6812","type":"print"},{"value":"1432-1416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]},"assertion":[{"value":"29 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"60"}}